Ketamine Infusions for the Treatment of Depression

Ketamine Infusions for the Treatment of Depression

Release Date: 09/21/2018
Expiration Date: 09/21/2021
Format: Internet Activity Enduring Material

Statement of Need/Program Overview

The purpose of this educational activity is to educate and enhance competency regarding the use of ketamine for treatment-resistant depression. With accumulating positive research on the use of intravenous ketamine for depression, it has entered clinical use as an off-label treatment for depression. In order to help guide safe treatment strategies, the effectiveness of ketamine on treating depression, including frequency, dose, and side-effects will be discussed.

Target Audience

The target audience for this activity is Medical Mutual's provider physician group and related healthcare professionals

Educational Objectives

After completing this activity, the participant should be better able to:

  1. Outline the indications of ketamine as an off-label treatment for the mainstream treatment of depression.
  2. Discuss the safe treatment of depression using intravenous ketamine, including frequency and dose.
  3. Identify the side-effects and long-term viability of using ketamine for the treatment of depression.

Accreditation Statement

Medical Mutual is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

Medical Mutual designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information about the accreditation of this program please contact the CME Team at 800.662.7917: or at .

Instructions to Receive CME Credit

In order to successfully complete the activity, participants must score 70% on the post test at the end of the activity and complete the course evaluations. Each participant has a maximum of three attempts to score a 70%. Successful completion is supported by a 70% pass rate at the end of the course, proving competency on the content of the activity.

Faculty and Disclosures

Medical Mutual requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity.

All identified conflicts of interest are thoroughly vetted by Medical Mutual for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The following reported no relevant financial relationships to products or devices that they or their spouse/life partner have with commercial interests related to the content of this CME activity

  • Greg L. Clary, MD, Sandhills Neurologists (Faculty)
  • Donna Nicholson, Vice President of Risk Management, Medical Mutual (Reviewer)
  • Anita Linton, Senior Risk Manager, Medical Mutual (Planner)
  • Lauren Hauser, Education Program Specialist, Medical Mutual (Planner)
  • Whitley Paige, Risk Management Coordinator, Medical Mutual (Planner)

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Medical Mutual does not recommend the use of an agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.

Not a guarantee that using information provided will prevent a claim against you or your practice.

Technical Requirements

This activity is best experienced using the most current browser (or one back) of Firefox, Chrome, Safari, Internet Explorer, or Microsoft Edge. For all activities featuring audio you must have a sound card and speakers. To view graphic images and references that appear in separate "pop-up" windows, you must have JavaScript and session cookies enabled on your computer. Adobe Acrobat Reader may be required for certain activities.

Select the Continue button below to begin. You may return later if you are unable to complete the activity at this time.